LUNG ALERT: No further tests for PE required in low probability cases with a negative D-dimer test

Bari, N.
November 2006
Thorax;Nov2006, Vol. 61 Issue 11, p961
Academic Journal
The article discusses a controlled trial that assessed the approach of omitting diagnostic testing of patients with suspected pulmonary embolism in reference to a negative D-dimer test result. The subjects were 1126 patients with suspected PE, and were grouped into low and high clinical probability groups. Symptomatic venous thromboembolism was followed up for over six months. Findings showed that additional diagnostic test can be conducted to a low probability PE and negative D-dimer test.


Related Articles

  • Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT. Reid, John H.; Coche, Emmanuel E.; Inoue, Tomio; Kim, Edmund E.; Dondi, Maurizio; Watanabe, Naoyuki; Mariani, Giuliano // European Journal of Nuclear Medicine & Molecular Imaging;Mar2009, Vol. 36 Issue 3, p505 

    The last decade has seen a changing pattern of utilization of multidetector CT (MDCT) versus lung perfusion scintigraphy in the investigation of pulmonary venous thromboembolism (VTE). In response to this the International Atomic Energy Agency (IAEA) determined that the subject required an...

  • Venous thromboembolism in pregnant woman - a challenge for the clinician. Diaconu, Camelia; Bălăceanu, Alice; Bartoş, Daniela // Central European Journal of Medicine;Oct2013, Vol. 8 Issue 5, p548 

    Deep vein thrombosis and pulmonary embolism are two clinical entities of a single disease called venous thromboembolism. Venous thromboembolism is an important cause of maternal morbidity and mortality. Diagnosis and treatment of venous thromboembolism in pregnant women are much more difficult...

  • Drug used for 35 days after THA reduced VTE rate by 80% vs. short-term prophylaxis. Rapp, Susan M. // Orthopedics Today;Aug2008, Vol. 28 Issue 8, p8 

    The article reports that results of the RECORD2 trial, or Regulation of Coagulation in Major Orthopaedic surgery reducing the Risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), showed that rivaroxaban used for 35 days after total hip arthroplasty (THA) reduced venous thromboembolic...

  • Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism. W. Eikelboom, John; McQuillan, Andrew; J. Quinlan, Daniel // Annals of Internal Medicine;2/3/2004, Vol. 140 Issue 3, p175 

    Background: Low-molecular-weight heparin has greatly simplified the management of deep venous thrombosis. However, for patients who present with pulmonary embolism, the role of low-molecular- weight heparin is uncertain and unfractionated heparin remains widely used. Purpose: To compare the...

  • A Comparison of ECG and Three Clinical Scoring Methods for the Diagnosis of Pulmonary Thromboembolism. Çetinkaya, Pelin Duru; Erer, Onur Fevzi; Özkan, Serir Aktoğu; Arı, Gülsüm // Turk Toraks Dergisi / Turkish Thoracic Journal;Mar2011, Vol. 12 Issue 1, p9 

    Objective: The clinical diagnosis of pulmonary thromboembolism (PTE) is unreliable because the most frequent symptoms are non-specific. The most important step in making the diagnosis of PTE is to clinically suspect the disease. The aim of the present study was to compare the diagnostic...

  • Risk Factors for Recurrent Venous Thromboembolism Revealed in PADIS-PE Trial. Cunningham, Muriel; Couturaud, Francis // MD Conference Express;Aug2015, Vol. 15 Issue 21, p8 

    The objective of the PADIS-PE study was to determine whether patients with 1 episode of unprovoked pulmonary embolism would benefit from an additional 18 months of oral anticoagulant treatment. Age, residual perfusion defects, and residual deep vein thrombosis were found to be independent risk...

  • The ENDORSE Study: Preventable Hospital Deaths.  // Clinical Oncology Alert;Apr2008 Primary Care, Vol. 13 Issue 4, p8 

    The article discusses a research on the lack of use of thromboprophylaxis (TPX) in patients who have pulmonary embolism (PUL-E) or venous thromboembolism (VTE). It references a study by A. T. Cohen et al, published in a 2008 issue of "The Lancet." Findings show that only more than half of the...

  • Diagnosing pulmonary embolism: new facts and strategies. Kelley, Mark A.; Carson, Jeffrey L.; Palevsky, Harold I.; Schwartz, J. Sanford; Kelley, M A; Carson, J L; Palevsky, H I; Schwartz, J S // Annals of Internal Medicine;2/15/91, Vol. 114 Issue 4, p300 

    Purpose: To provide a clinical approach to the diagnosis of pulmonary embolism. Data Identification: An English-language literature search using MEDLINE (1982 to 1990) and bibliographic reviews of textbooks and review articles. Study Selection: In addition...

  • The Prevention of Venous Thromboembolism in Older Adults: Guidelines. Aronow, Wilbert S. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jan2004, Vol. 59 Issue 1, p42 

    The rationale for thromboprophylaxis is based on the high prevalence of venous thromboembolism (VTE), a disorder involving deep vein thrombosis (DVT) and pulmonary embolism (PE), among hospitalized patients, the clinically silent nature of VTE in most patients, and the morbidity, cost, and...


Read the Article


Sign out of this library

Other Topics